Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the Quarter and Half year ended 30 September 2026